Cycle-Aware Pelvic Health Care: Why We Should Track Patterns, Not Prescribe by Phase
How menstrual-cycle physiology may influence pain, exercise tolerance, and treatment
Why the Menstrual Cycle Belongs in Your Clinical Reasoning
A patient's pelvic pain on day 2 of her cycle may look very different from that same patient's pain on day 12. Same diagnosis. Same tissues. Same clinician. Different hormonal environment—and potentially a very different clinical presentation.
Fluctuations in estrogen, progesterone, prostaglandins, and other physiologic mediators across the menstrual cycle may influence symptoms ranging from pelvic pain and bowel function to sleep, mood, energy, and exercise tolerance. For some patients, those fluctuations are barely noticeable. For others—particularly those with conditions such as dysmenorrhea, endometriosis, migraine, irritable bowel syndrome, or bladder pain syndrome—they may be clinically significant.
And yet menstrual-cycle patterns aren't always part of the pelvic health evaluation. This doesn't mean we should build treatment protocols around cycle day.
Quite the opposite.
Research examining pain, exercise performance, and cognition across the menstrual cycle is mixed, and individual responses vary considerably. Cycle phase should therefore be viewed as one potential contributor to the patient's presentation—not a prescription for how they will feel or perform.
The better clinical question isn't “What should I do differently because she's in the luteal phase?”, it's “Does this patient demonstrate a meaningful cyclical pattern—and if so, how should that information influence today's clinical decisions?”
Understanding the physiology gives us context. Tracking the individual gives us clinically useful information. Let's look at both.
The Four Phases at a Glance
A textbook menstrual cycle is often described as 28 days, although normal cycle length varies considerably. The follicular phase accounts for much of that variability, while the luteal phase tends to be more consistent.
Phase | Typical days | What's happening | Hormone snapshot |
Early follicular | Days 1–5 | Menstruation; new follicles begin developing | Estrogen and progesterone both low; FSH rising; prostaglandins high |
Late follicular | Days 6–14 | Dominant follicle matures; ovulation around day 14 | Estrogen climbs to its peak; LH and FSH surge just before ovulation |
Early luteal | Days 15–21 | Corpus luteum forms and supports the uterine lining | Progesterone rises to its peak; estrogen makes a second, smaller rise |
Late luteal | Days 22–28 | Corpus luteum regresses if no pregnancy | Estrogen and progesterone both fall; PMS window |
*Days are illustrative for a 28-day ovulatory cycle and should not be used to assume an individual's cycle phase.
Patients using hormonal contraception, those in perimenopause, and those with irregular or anovulatory cycles will not necessarily follow this pattern.
Beyond Estrogen and Progesterone
Estrogen and progesterone tend to get most of the attention, but they're not the only physiologic players relevant to pelvic health.
Prostaglandins, particularly around menstruation, contribute to uterine contractions and may influence cramping and bowel symptoms.
Allopregnanolone, a neuroactive metabolite of progesterone, interacts with GABA-A receptors and fluctuates alongside progesterone.
Changes in thermoregulation, substrate utilization, sleep, gastrointestinal function, and fluid balance may also occur throughout the cycle.
The most important piece to this is that the physiology may provide a plausible mechanism, but it does not tell us exactly how an individual patient will feel.
Phase by Phase: What Might Clinicians Notice?
Research examining menstrual-cycle effects is mixed, and individual variation is substantial. The patterns below should be treated as things to screen for—not rules to prescribe by.
Early Follicular: Menstruation and the Low-Hormone Window
Pain + pelvic symptoms
Prostaglandins contribute to uterine contractions during menstruation and may contribute to cramping, low-back or thigh symptoms, and changes in bowel function.
Research in healthy, pain-free populations has not consistently demonstrated meaningful changes in pain perception across menstrual-cycle phases. However, individuals with dysmenorrhea may demonstrate greater pain sensitivity overall, and some clinical pain conditions—including endometriosis, migraine, IBS, and bladder pain syndrome—may fluctuate around menstruation.
That distinction matters. Cycle phase doesn't automatically make someone more pain-sensitive. But an individual patient may demonstrate a very consistent pattern of increased symptoms during menstruation.
Energy + exercise
Pain, sleep disruption, menstrual symptoms, and individual bleeding patterns may influence energy and perceived exercise tolerance.
Importantly, menstruation itself does not mean a patient is incapable of strength or higher-intensity exercise. Research examining exercise performance across the menstrual cycle demonstrates considerable individual variability, with relatively small average differences between phases. Ask how the patient feels, don't assume how she will perform.
Late Follicular: The Rising-Estrogen Window
As estrogen rises and progesterone remains relatively low, physiologic changes may influence substrate utilization, thermoregulation, recovery, and training response.
Some patients report feeling particularly energetic or capable during this portion of their cycle. Others notice very little difference. Some may also experience mittelschmerz, or ovulation-associated pain, which is typically short-lived and often unilateral.
The late follicular phase is sometimes described as a universal “high-performance window,” but the evidence doesn't support using cycle phase alone to determine exercise progression. If a patient consistently reports better energy, recovery, or exercise tolerance during this portion of her cycle, that's useful information.
The patient's pattern matters more than the textbook pattern.
Early Luteal: The Higher-Progesterone Window
Following ovulation, progesterone rises and estrogen has a smaller secondary increase. Progesterone is associated with an increase in resting core temperature, which may influence thermoregulation and perceived exertion—particularly during prolonged exercise or exercise in hot environments.
Some patients also report changes in bowel function, bloating, sleep, or energy during the luteal phase.
Again, these are potential physiologic influences, not predetermined symptoms.
For pelvic health clinicians, this is another opportunity to ask:
Has bowel function changed?
Is bloating affecting pressure or comfort?
Does exercise feel different?
Has sleep changed?
Is this consistent with previous cycles?
Late Luteal: The Hormone-Withdrawal Window
If pregnancy does not occur, estrogen and progesterone decline as the cycle approaches menstruation.
For some patients, this corresponds with a predictable increase in premenstrual symptoms, including headache or migraine, breast tenderness, bloating, pelvic heaviness, fatigue, mood changes, sleep disruption, or increased pain. For others, very little changes.
Patients with premenstrual dysphoric disorder (PMDD) may experience significant affective and functional symptoms during this phase and warrant appropriate medical and/or mental health referral.
The clinical takeaway is not that the late luteal phase is inherently a “high-sensitivity phase.” Rather, for some patients, the late luteal and early follicular phases may represent a recurring window of increased symptoms or sensitivity. Track for the pattern rather than assuming it.
What Does This Mean for Pelvic Health Treatment?
Here's where cycle-aware care can easily become another protocol.
Early follicular? Back off.
Late follicular? Progress.
Late luteal? Back off again.
That's not what the evidence tells us, and it's not how we should practice.
Cycle phase alone should not determine treatment dosage, exercise progression, or expectations for how a patient will respond. What the menstrual cycle can provide is additional context.
If a patient consistently experiences increased pain sensitivity, fatigue, dysmenorrhea, migraine, poor sleep, bowel changes, or heightened symptom irritability during a particular portion of her cycle, that information may influence what makes sense for that patient on that day.
Conversely, if a patient feels strong, well-rested, minimally symptomatic, and ready to progress during menstruation, there is no reason to automatically reduce exercise intensity simply because she's on day 2.
Treat the presentation, not the calendar.
What Does This Mean for Dry Needling?
The same principle applies to dry needling.
There is currently insufficient evidence to prescribe dry needling dosage according to menstrual-cycle phase alone. A patient does not automatically require fewer needles because she is menstruating. And being in the late follicular phase isn't permission to increase treatment intensity simply because estrogen is higher.
Instead, assess the nervous system in front of you.
Consider:
How irritable are her symptoms today?
What is her current pain sensitivity?
How did she respond to the previous treatment?
How is she sleeping?
What is her energy level?
Is she experiencing significant cramping, headache, bowel changes, or other cyclical symptoms?
How reactive is her system to sensory input today?
What does she need to accomplish after the session?
Then dose accordingly.
Cycle tracking may help you recognize that the same patient repeatedly presents differently at particular points in her cycle. That pattern can inform clinical reasoning. Cycle day alone should not.
Dry needling is not a protocol. The menstrual cycle shouldn't become one either.
Putting It Into Practice
Cycle-aware care doesn't require turning every pelvic health visit into an endocrinology consult. It requires asking better questions.
Document cycle timing when it's clinically relevant. Rather than simply recording “day 17,” ask whether symptoms consistently change around menstruation, ovulation, or the premenstrual window.
Track symptoms alongside the cycle. One difficult visit isn't a pattern. Several cycles of similar symptom behavior may be.
Compare like with like when useful. If an outcome measure appears to fluctuate considerably with symptoms, cycle timing may provide useful context when interpreting change over time.
Dose treatment to the patient in front of you. Pain sensitivity, fatigue, sleep, previous treatment response, symptom irritability, goals, and overall clinical presentation should guide treatment intensity.
Screen and refer appropriately. Severe or progressively worsening menstrual or pelvic pain should not simply be normalized as “part of having a period.” Conditions including endometriosis, adenomyosis, fibroids, migraine, and PMDD may require additional medical evaluation.
And perhaps most importantly, don't label a predictable flare as treatment failure without first understanding the pattern.
Coaching Patients to Find Their Pattern
One of the simplest interventions we can offer is also one of the most useful: track the menstrual cycle alongside symptoms. Rather than telling patients how they should feel during each phase, encourage them to observe what actually happens.
Consider tracking:
pelvic pain
cramping
bowel and bladder symptoms
headache or migraine
sleep
perceived exertion
energy and fatigue
recovery
mood
exercise tolerance
After two to three cycles, look at the data together.
Are symptoms consistently worse before menstruation?
Does constipation reliably appear during a particular portion of the cycle?
Do migraines cluster around hormone withdrawal?
Does exercise actually feel harder—or has the patient been told that it should?
Does pelvic pain flare predictably and then return to baseline?
Sometimes there will be a clear pattern, sometimes there won't. Both are useful information. The goal isn't to fit the patient into the textbook menstrual cycle, it's to understand her cycle.
Tips That Apply All Month
Reframe predictable flares. If a patient has established a consistent cyclical pattern, a temporary increase in symptoms doesn't necessarily indicate tissue damage, regression, or treatment failure.
Adjust, don't automatically abandon. Exercise can often be modified on more symptomatic days rather than eliminated altogether.
Bring the data to appointments. Cycle and symptom tracking may provide useful information for the entire healthcare team.
Consider the whole team. Pelvic health rehabilitation, gynecology, primary care, sports medicine, nutrition, and mental health professionals may all have roles depending on the patient's presentation.
Bottom Line
The menstrual cycle creates real physiologic changes. But physiology is not destiny.
Estrogen, progesterone, prostaglandins, neuroactive steroids, thermoregulation, sleep, gastrointestinal function, and other factors may contribute to changes in how a patient feels and functions across the month.
What we shouldn't do is turn those physiologic changes into another rigid treatment algorithm. Being cycle-aware doesn't mean assuming menstruation requires less exercise, the follicular phase requires more loading, or the luteal phase requires a different dry needling dose.
It means understanding the physiology, asking better questions, identifying meaningful patterns, and adjusting treatment when the patient's presentation tells us to—not simply because an app says she's on day 24.
At PPHC, we believe great outcomes come from clinical reasoning, not protocols. Knowing when, why, and how much to treat matters just as much as knowing what to treat.
And the menstrual cycle? It's another piece of the clinical picture, not a protocol.
Track the pattern. Treat the person.
This post provides general educational information for healthcare professionals and is not medical advice. Menstrual-cycle timing, hormone concentrations, symptoms, and physiologic responses vary considerably between individuals.
References
Reed BG, Carr BR. The normal menstrual cycle and the control of ovulation. In: Endotext. MDText.com; updated 2018. NCBI Bookshelf
Iacovides S, Avidon I, Baker FC. Does pain vary across the menstrual cycle? A review. Eur J Pain. 2015;19(10):1389–1405. doi:10.1002/ejp.714
Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21(6):762–778. doi:10.1093/humupd/dmv039
Iacovides S, Baker FC, Avidon I, Bentley A. Women with dysmenorrhea are hypersensitive to experimental deep muscle pain across the menstrual cycle. J Pain. 2013;14(10):1066–1076.
McNulty KL, Elliott-Sale KJ, Dolan E, et al. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta-analysis. Sports Med. 2020;50(10):1813–1827. doi:10.1007/s40279-020-01319-3
Baker FC, Siboza F, Fuller A. Temperature regulation in women: effects of the menstrual cycle. Temperature. 2020;7(3):226–262. doi:10.1080/23328940.2020.1735927
Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020;12:100213. doi:10.1016/j.ynstr.2020.100213
Modzelewski S, Oracz A, Żukow X, et al. Premenstrual syndrome: new insights into etiology and review of treatment methods. Front Psychiatry. 2024;15:1363875. doi:10.3389/fpsyt.2024.1363875
Proctor M, Farquhar C, Stones W, et al. Transcutaneous electrical nerve stimulation for primary dysmenorrhoea.Cochrane Database Syst Rev. 2002;(1):CD002123.doi:10.1002/14651858.CD002123
Comments